POLA ORBIS (PORBF)
(Delayed Data from OTC)
$9.40 USD
0.00 (0.00%)
Updated Aug 5, 2024 09:30 AM ET
2-Buy of 5 2
C Value C Growth A Momentum C VGM
Income Statements
Fiscal Year end for POLA ORBIS falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,230 | 1,265 | 1,626 | 1,657 | 2,023 |
Cost Of Goods | 222 | 236 | 261 | 282 | 331 |
Gross Profit | 1,009 | 1,029 | 1,364 | 1,376 | 1,693 |
Selling & Adminstrative & Depr. & Amort Expenses | 890 | 928 | 1,204 | 1,239 | 1,399 |
Income After Depreciation & Amortization | 119 | 102 | 160 | 136 | 293 |
Non-Operating Income | 3 | 4 | 14 | -35 | -4 |
Interest Expense | 1 | 1 | 1 | 1 | 1 |
Pretax Income | 109 | 94 | 160 | 86 | 274 |
Income Taxes | 40 | 6 | 53 | 43 | 93 |
Minority Interest | 0 | 0 | 1 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 69 | 88 | 107 | 44 | 181 |
Extras & Discontinued Operations | -22 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 69 | 87 | 107 | 44 | 181 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 174 | 168 | 228 | 205 | 361 |
Depreciation & Amortization (Cash Flow) | 55 | 67 | 67 | 68 | 68 |
Income After Depreciation & Amortization | 119 | 102 | 160 | 136 | 293 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 221.47 | 221.44 | 221.23 | 221.20 | 221.46 |
Diluted EPS Before Non-Recurring Items | 0.41 | 0.49 | 0.54 | 0.34 | 0.85 |
Diluted Net EPS (GAAP) | 0.36 | 0.40 | 0.48 | 0.20 | 0.82 |
Fiscal Year end for POLA ORBIS falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 275.51 | 273.94 | 315.34 | 283.09 | 318.40 |
Cost Of Goods | NA | 49.31 | NA | NA | NA |
Gross Profit | NA | 224.62 | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 202.11 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.51 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | 8.27 | NA | NA | NA |
Interest Expense | NA | 0.19 | NA | NA | NA |
Pretax Income | NA | 30.57 | NA | NA | NA |
Income Taxes | NA | 9.55 | NA | NA | NA |
Minority Interest | NA | 0.06 | NA | NA | NA |
Investment Gains/Losses | NA | 0.00 | NA | NA | NA |
Other Income/Charges | NA | 0.00 | NA | NA | NA |
Income From Cont. Operations | 28.78 | 21.01 | 16.77 | 15.39 | 34.32 |
Extras & Discontinued Operations | -0.73 | -0.75 | -14.19 | -2.37 | -0.36 |
Net Income (GAAP) | 28.06 | 20.94 | 2.58 | 13.01 | 33.96 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 221.58 | 221.39 | 221.51 | 221.24 | 221.53 |
Diluted EPS Before Non-Recurring Items | 0.13 | 0.10 | 0.07 | 0.07 | 0.15 |
Diluted Net EPS (GAAP) | 0.13 | 0.10 | 0.01 | 0.06 | 0.15 |